Sudarshan Chemical Industries Limited announces an acquisition

VP4 Frankfurt GmbH did not contribute to Sudarshan’s reported FY24 consolidated results. VP4 became part of Sudarshan through the Heubach acquisition ^[1], and that acquisition was completed on 4 March 2025 ^[2]—after FY24 ended on 31 March 2024. Therefore, its FY24 contribution to Sudarshan’s actual consolidated revenue and EBITDA is nil/not applicable, rather than a separately reported operating contribution.

If “FY24” refers to VP4’s own historical performance for pro-forma transaction analysis, its revenue and EBITDA are not separately reported in the cited material.

Implication for Pigments margins

The exclusion cannot be quantified from the disclosed figures:

• FY24 Pigments revenue was reported at INR 22,232 million, equivalent to Rs 2,223.20 Cr, but segment EBITDA or EBITDA margin was not reported in the cited segment table ^[3].
• VP4 manufactures intermediates, primarily as a tolling operator for Nutrinova, with only a small portion of output supplied to Sudarshan for captive use ^[1]. This supports its treatment as a non-core activity, but the exact segment classification and inter-segment eliminations are not disclosed.
• If VP4 was outside the Pigments segment, its exclusion would have no direct effect on the Pigments EBITDA margin; it would only reduce consolidated revenue and EBITDA.
• If VP4 was included within Pigments, the pro-forma margin would be:

`Pro-forma Pigments EBITDA margin = (Reported Pigments EBITDA − VP4 EBITDA) / (Reported Pigments revenue − VP4 revenue)`

The margin would rise if VP4’s EBITDA margin was below the reported Pigments margin, and fall if it was above it.

Bottom line: the transaction improves Sudarshan’s strategic focus on pigments, but a numerical pro-forma Pigments margin uplift—or even its direction—cannot be established without VP4’s standalone FY24 revenue, EBITDA and segment allocation.

Expected impact: The EUR 76.5 Mn proceeds are intended primarily to prepay the acquisition loan used for the Heubach transaction, so consolidated gross debt should decline materially after closing. Management expects the transaction to take the company to zero net debt or a net-cash position once the proceeds are applied. The deal is expected to close in approximately 2–3 months. ^[4]

The practical interpretation is:

• Gross debt reduction: potentially up to EUR 76.5 Mn if the full consideration is used for loan repayment, although the company says “primarily,” so the actual reduction may be lower after transaction adjustments or other uses.
• Financing type: the company specifically refers to an acquisition loan; the disclosure does not separately identify or quantify a bridge loan.
• Net debt outcome: management’s stated objective is not merely lower leverage but zero net debt / positive cash after the prepayment. This refers to net debt, so it does not necessarily mean all gross borrowings will be extinguished.
• Key limitation: the exact outstanding balance of the Heubach acquisition financing, the portion classified as bridge debt, and the post-transaction gross-debt figure are not provided. Therefore, EUR 76.5 Mn should be treated as the maximum potential gross-debt reduction, not a confirmed one-for-one reduction.

The disclosed terms are high-level: the sale remains subject to condition precedents and customary closing conditions, but no specific regulatory approval is named. Completion was expected in approximately 2–3 months from the 1 September 2026 presentation. ^{[5] [4]}

Transaction terms and cash proceeds

• Headline consideration: EUR 76.5 million for the sale of VP4 Frankfurt GmbH. ^[4]
• Use of proceeds: Sudarshan said the proceeds would be used primarily to prepay the acquisition loan; the stated objective was to become a zero-net-debt or positive-cash company after closing. ^[4]
• Earn-out: No earn-out or performance-linked contingent consideration is identified in the disclosed transaction summary.
• Deferred consideration: No instalment schedule, escrow, deferred payment, or completion-account adjustment is disclosed.
• Tax liabilities: No tax charge, withholding-tax treatment, capital-gains tax estimate, transaction costs, or other deductions from the EUR 76.5 million are quantified in the disclosed materials.

Implication: EUR 76.5 million should be treated as the headline transaction value, not yet as confirmed net cash inflow. The eventual cash available to reduce debt could be lower if the definitive agreements include taxes, fees, escrow/working-capital adjustments, debt-like items, or deferred consideration, but the cited disclosures do not quantify any such adjustments.

The key remaining diligence item is therefore the definitive sale documentation: it should clarify the named condition precedents, any merger-control or other regulatory clearances, payment timing, completion-account mechanics, indemnity/escrow provisions, and the tax allocation between the parties.